Please login to the form below

Not currently logged in

Website to boost numbers in clinical trials

Quintiles has launched a new website to help drive awareness, understanding and participation in clinical research around the world

Quintiles has launched a new website to help drive awareness, understanding and, ultimately, participation in clinical research around the world.

The website,, is aimed towards the general public and attempts to explain the critical role of clinical research in identifying cures and therapies. It also enables potential patients to identify clinical trials to participate in, regardless of geography or the drug company sponsor.

Quintiles, a global biopharmaceutical services company, believes that the lack of participation in trials is one of the major factors in delaying the development of new drugs. It argues that with a greater understanding of clinical research and appreciation of its value, more people will be willing to participate in clinical trials.

"Research shows that 75 per cent of the general public state they have little or no knowledge of clinical research and the participation process. We want to fundamentally change that statistic," said Chris Cabell, head of global access to patients at Quintiles.

"If patients and their families are more aware of the opportunities that clinical research can provide, they will be better able to make informed decisions about participating in research and helping drive the development of new and better medicines," Cabell adds.

Visitors to the site can identify ongoing or future clinical trials appropriate for their disease or condition and narrow them down to their local georgraphic area. Patients will also be able to watch videos describing real-life patient experiences, read results from recent studies, and connect with other individuals about their insight into clinical research.

Since 1962, the FDA has approved 1,019 novel therapies. Virtually all the medicines used today are a result of clinical research, including all drugs for cancer, heart disease, depression, HIV, Alzheimer's and asthma. These new medicines have increased life expectancy by 10 years.

15th October 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....